JavaScript scheint in Ihrem Browser deaktiviert zu sein. Sie müssen JavaScript in Ihrem Browser aktivieren, um alle Funktionen in diesem Shop nutzen zu können.
Esophageal carcinoma Origin: Established from the adenocarcinoma of the lower oesophagus (Barrett's metaplasia), equivalent to JROECL33 Species:Homo sapiens Tissue:Esophagus Morphology:Epithelial Properties:Adherent Cytogenic data:Express HLA-A, -B and -C antigens (MHC class I) and ICAM-1 constitutively. Expression of HLA-DR (MHC class II) can be induced by treatment with interferon-gamma. The cells express epithelial cytokeratins and are tumourigenic in nude mice Patient:Female, Caucasian, 73 years of age Medium:AddexBio-formulated RPMI-1640 Medium(C0004-01) + 10% FBS Subculture:1:3 to 1:5 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Protein Expression: cytokeratin +, cytokeratin-7 +, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, cytokeratin-19 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -, vimentin - Mutations in OE33 Cells Related cells by Organ: EC-109 cells HKESC-1 cells OE33 cells JROECL33 cells NE-1 cells
Established from the adenocarcinoma of the lower oesophagus (Barrett's metaplasia), equivalent to JROECL33 Species:Homo sapiens Tissue:Esophagus Morphology:Epithelial Properties:Adherent Cytogenic data:Express HLA-A, -B and -C antigens (MHC class I) and ICAM-1 constitutively. Expression of HLA-DR (MHC class II) can be induced by treatment with interferon-gamma. The cells express epithelial cytokeratins and are tumourigenic in nude mice Patient:Female, Caucasian, 73 years of age Medium:AddexBio-formulated RPMI-1640 Medium(C0004-01) + 10% FBS Subculture:1:3 to 1:5 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Protein Expression: cytokeratin +, cytokeratin-7 +, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, cytokeratin-19 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -, vimentin - Mutations in OE33 Cells Related cells by Organ: EC-109 cells HKESC-1 cells OE33 cells JROECL33 cells NE-1 cells
Homo sapiens Tissue:Esophagus Morphology:Epithelial Properties:Adherent Cytogenic data:Express HLA-A, -B and -C antigens (MHC class I) and ICAM-1 constitutively. Expression of HLA-DR (MHC class II) can be induced by treatment with interferon-gamma. The cells express epithelial cytokeratins and are tumourigenic in nude mice Patient:Female, Caucasian, 73 years of age Medium:AddexBio-formulated RPMI-1640 Medium(C0004-01) + 10% FBS Subculture:1:3 to 1:5 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Protein Expression: cytokeratin +, cytokeratin-7 +, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, cytokeratin-19 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -, vimentin - Mutations in OE33 Cells Related cells by Organ: EC-109 cells HKESC-1 cells OE33 cells JROECL33 cells NE-1 cells
Esophagus Morphology:Epithelial Properties:Adherent Cytogenic data:Express HLA-A, -B and -C antigens (MHC class I) and ICAM-1 constitutively. Expression of HLA-DR (MHC class II) can be induced by treatment with interferon-gamma. The cells express epithelial cytokeratins and are tumourigenic in nude mice Patient:Female, Caucasian, 73 years of age Medium:AddexBio-formulated RPMI-1640 Medium(C0004-01) + 10% FBS Subculture:1:3 to 1:5 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Protein Expression: cytokeratin +, cytokeratin-7 +, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, cytokeratin-19 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -, vimentin - Mutations in OE33 Cells Related cells by Organ: EC-109 cells HKESC-1 cells OE33 cells JROECL33 cells NE-1 cells
Epithelial Properties:Adherent Cytogenic data:Express HLA-A, -B and -C antigens (MHC class I) and ICAM-1 constitutively. Expression of HLA-DR (MHC class II) can be induced by treatment with interferon-gamma. The cells express epithelial cytokeratins and are tumourigenic in nude mice Patient:Female, Caucasian, 73 years of age Medium:AddexBio-formulated RPMI-1640 Medium(C0004-01) + 10% FBS Subculture:1:3 to 1:5 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Protein Expression: cytokeratin +, cytokeratin-7 +, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, cytokeratin-19 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -, vimentin - Mutations in OE33 Cells Related cells by Organ: EC-109 cells HKESC-1 cells OE33 cells JROECL33 cells NE-1 cells
Adherent Cytogenic data:Express HLA-A, -B and -C antigens (MHC class I) and ICAM-1 constitutively. Expression of HLA-DR (MHC class II) can be induced by treatment with interferon-gamma. The cells express epithelial cytokeratins and are tumourigenic in nude mice Patient:Female, Caucasian, 73 years of age Medium:AddexBio-formulated RPMI-1640 Medium(C0004-01) + 10% FBS Subculture:1:3 to 1:5 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Protein Expression: cytokeratin +, cytokeratin-7 +, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, cytokeratin-19 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -, vimentin - Mutations in OE33 Cells Related cells by Organ: EC-109 cells HKESC-1 cells OE33 cells JROECL33 cells NE-1 cells
Express HLA-A, -B and -C antigens (MHC class I) and ICAM-1 constitutively. Expression of HLA-DR (MHC class II) can be induced by treatment with interferon-gamma. The cells express epithelial cytokeratins and are tumourigenic in nude mice Patient:Female, Caucasian, 73 years of age Medium:AddexBio-formulated RPMI-1640 Medium(C0004-01) + 10% FBS Subculture:1:3 to 1:5 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Protein Expression: cytokeratin +, cytokeratin-7 +, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, cytokeratin-19 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -, vimentin - Mutations in OE33 Cells Related cells by Organ: EC-109 cells HKESC-1 cells OE33 cells JROECL33 cells NE-1 cells
Female, Caucasian, 73 years of age Medium:AddexBio-formulated RPMI-1640 Medium(C0004-01) + 10% FBS Subculture:1:3 to 1:5 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Protein Expression: cytokeratin +, cytokeratin-7 +, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, cytokeratin-19 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -, vimentin - Mutations in OE33 Cells Related cells by Organ: EC-109 cells HKESC-1 cells OE33 cells JROECL33 cells NE-1 cells
AddexBio-formulated RPMI-1640 Medium(C0004-01) + 10% FBS Subculture:1:3 to 1:5 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Protein Expression: cytokeratin +, cytokeratin-7 +, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, cytokeratin-19 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -, vimentin - Mutations in OE33 Cells Related cells by Organ: EC-109 cells HKESC-1 cells OE33 cells JROECL33 cells NE-1 cells
1:3 to 1:5 using 0.25% trypsin or trypsin/EDTA, 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Protein Expression: cytokeratin +, cytokeratin-7 +, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, cytokeratin-19 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -, vimentin - Mutations in OE33 Cells Related cells by Organ: EC-109 cells HKESC-1 cells OE33 cells JROECL33 cells NE-1 cells
Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Protein Expression: cytokeratin +, cytokeratin-7 +, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, cytokeratin-19 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -, vimentin - Mutations in OE33 Cells Related cells by Organ: EC-109 cells HKESC-1 cells OE33 cells JROECL33 cells NE-1 cells
Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Protein Expression: cytokeratin +, cytokeratin-7 +, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, cytokeratin-19 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -, vimentin - Mutations in OE33 Cells Related cells by Organ: EC-109 cells HKESC-1 cells OE33 cells JROECL33 cells NE-1 cells
Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Protein Expression: cytokeratin +, cytokeratin-7 +, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, cytokeratin-19 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -, vimentin - Mutations in OE33 Cells Related cells by Organ: EC-109 cells HKESC-1 cells OE33 cells JROECL33 cells NE-1 cells
Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Protein Expression: cytokeratin +, cytokeratin-7 +, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, cytokeratin-19 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -, vimentin - Mutations in OE33 Cells Related cells by Organ: EC-109 cells HKESC-1 cells OE33 cells JROECL33 cells NE-1 cells
HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Protein Expression: cytokeratin +, cytokeratin-7 +, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, cytokeratin-19 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -, vimentin - Mutations in OE33 Cells Related cells by Organ: EC-109 cells HKESC-1 cells OE33 cells JROECL33 cells NE-1 cells
Hepatitis B: Negative Hepatitis C: Negative Protein Expression: cytokeratin +, cytokeratin-7 +, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, cytokeratin-19 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -, vimentin - Mutations in OE33 Cells Related cells by Organ: EC-109 cells HKESC-1 cells OE33 cells JROECL33 cells NE-1 cells
Hepatitis C: Negative Protein Expression: cytokeratin +, cytokeratin-7 +, cytokeratin-8 +, cytokeratin-17 -, cytokeratin-18 +, cytokeratin-19 +, desmin -, endothel -, EpCAM +, GFAP -, neurofilament -, vimentin - Mutations in OE33 Cells Related cells by Organ: EC-109 cells HKESC-1 cells OE33 cells JROECL33 cells NE-1 cells
Mutations in OE33 Cells
EC-109 cells
HKESC-1 cells
OE33 cells
JROECL33 cells
NE-1 cells
Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.
Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.
C0013003.pdf
Sicherheitsdatenblatt anfordern
Lieferung vsl. bis 11.09.2025
Vergleichen
Auf den Wunschzettel
Angebot anfordern
Lieferzeit anfragen
Technische Frage stellen
Bulk-Anfrage stellen
sales@hoelzel.de
« Zurück
Pünktliche Lieferung zu Ihrem Wunschtermin und bei jeder 5. Bestellung 15% sparen.
Passwort vergessen?
Noch nicht registriert? Konto hier erstellen!